PMID: 8590957Jan 1, 1996Paper

An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency

European Journal of Endocrinology
P GarryJ G Devlin

Abstract

Interest in adult growth hormone replacement has increased since identification of the associated vascular morbidity and mortality. Although total cholesterol and low density lipoprotein reduction and high density lipoprotein increases are anticipated, reports are conflicting and there is no uniformity in lipoprotein(a) changes. In 1990 we commenced an open trial of therapy with human recombinant GH and now have results to 36 months for 21 patients. Deficiency status was confirmed by insulin stress test with flat GH response < 2.0 ng/ml, mean insulin-like growth factor-I value 122 ng/ml (+/- 69 SD). Lipoprotein(a) was measured by monoclonal assay. Lipid analysis yields two subgroups: baseline cholesterol levels of greater or less than 6.22 mmol/l, with hypercholesterolaemic patients showing an enhanced hypolipaemic response. ANOVA was utilized, with 95% confidence limits. The most significant changes are of reductions in cholesterol and low density lipoprotein; the rate of change is greatest at 6 and 12 months but not sustained to 36 months. High density lipoprotein rises as expected, not to full significance. Lipoprotein(a) levels rose significantly in six patients of the cohort, and the increase was sustained over 36 months.

Citations

Jan 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Torben Laursen
Jun 10, 1998·Psychoneuroendocrinology·J B DeijenE A van der Veen
Jul 6, 2000·Trends in Endocrinology and Metabolism : TEM·A L BarkanW F Young
Apr 15, 2008·Trends in Endocrinology and Metabolism : TEM·E R ChristD L Russell-Jones
Mar 10, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A ErmanC G Goodyer
Apr 18, 2008·Der Internist·M Faust, C J Strasburger
Oct 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J R HarrisT Chiller
Mar 20, 1999·Baillière's Clinical Endocrinology and Metabolism·F L HewJ D Best
Feb 13, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P E Clayton, C T Cowell
Jul 20, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Helen SimpsonUNKNOWN GRS Council
Jul 27, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·G Johannsson, J O Jørgensen
May 9, 2012·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Maria Claudia Peixoto CenciFlávia Lúcia Conceição
Apr 10, 1999·Clinical Endocrinology·G P LeeseI A MacFarlane
Jul 9, 2002·Clinical Endocrinology·Roland W McCallumJohn M C Connell
Dec 6, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Suzanne LindBo Angelin
Apr 24, 2014·Journal of Pediatric Endocrinology & Metabolism : JPEM·Marilza de Jesus ModestoLuiz De Lacerda
Aug 12, 1999·The Journal of Clinical Endocrinology and Metabolism·J GibneyD Russell-Jones
Aug 1, 1997·The Journal of Clinical Endocrinology and Metabolism·K A al-ShoumerD G Johnston
May 10, 2002·Pediatric Transplantation·L GhioA Edefonti
Dec 15, 2007·Metabolism: Clinical and Experimental·Maria Claudia Peixoto CenciMario Vaisman

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.